Compare SHAK & SHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SHAK | SHC |
|---|---|---|
| Founded | 2004 | 2015 |
| Country | United States | United States |
| Employees | N/A | 3000 |
| Industry | Restaurants | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 5.2B |
| IPO Year | 2014 | 2020 |
| Metric | SHAK | SHC |
|---|---|---|
| Price | $57.23 | $18.46 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 26 | 7 |
| Target Price | ★ $117.29 | $20.33 |
| AVG Volume (30 Days) | 1.1M | ★ 1.7M |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 354.17 | 68.75 |
| EPS | ★ 0.37 | 0.28 |
| Revenue | ★ $1,445,306,000.00 | $1,163,617,000.00 |
| Revenue This Year | $16.58 | $7.51 |
| Revenue Next Year | $15.07 | $6.00 |
| P/E Ratio | $158.03 | ★ $65.32 |
| Revenue Growth | ★ 15.38 | 5.74 |
| 52 Week Low | $51.60 | $13.09 |
| 52 Week High | $107.46 | $19.85 |
| Indicator | SHAK | SHC |
|---|---|---|
| Relative Strength Index (RSI) | 38.40 | 42.83 |
| Support Level | $52.90 | $18.20 |
| Resistance Level | $62.24 | $18.55 |
| Average True Range (ATR) | 2.56 | 0.41 |
| MACD | -0.58 | -0.08 |
| Stochastic Oscillator | 23.10 | 16.56 |
Shake Shack Inc is a roadside burger stand. It serves a classic American menu of premium burgers, hot dogs, crispy chicken, frozen custard, crinkle-cut fries, shakes, beer, wine, and more. The company's burgers are made with a whole-muscle blend of all-natural, hormone and antibiotic-free Angus beef, ground fresh daily, cooked to order, and served on a non-genetically modified organism (GMO) potato bun. Its menu focuses on food and beverages, crafted from a range of classic American foods. The company serves draft Root Beer, seasonal freshly-squeezed lemonade, organic fresh-brewed iced tea, cold brew coffee, organic apple juice, and Shack20 bottled water. Geographically, the company generates the majority of its revenue from the United States.
Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical, and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three reportable segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment, which generates maximum revenue, provides outsourced terminal sterilization and irradiation services for medical devices, pharmaceuticals, food safety, and other application markets using three core technologies: gamma irradiation, EO processing, and E-beam irradiation. Geographically, the company generates maximum revenue from the United States, followed by Canada, Europe, and other regions.